With an established moviemaking hub so close in Vancouver, B.C., Seattle is probably never going to be ground zero for a lot of Hollywood productions. But this area’s entrepreneurs, with rich DNA in digital media, gaming, and e-commerce, could certainly make some waves by helping the entertainment industry navigate the digital era. In this piece, … Continue reading “Hollywood Lights, Rock Gods, Cleantech Gurus, & More in the Seattle-Area Tech Roundup”
Category: National
Madrona, Trilogy Lead $1.2M Investment in Mobilisafe, Targeting Business IT Security Amid a Flood of Personal Gadgets
Aside from the occasional panic over distracted driving or general griping about bad manners, the rapid improvement in personal mobile computing over the past decade is usually portrayed as a happy occurrence. But the phenomenon is also creating a range of headaches for business IT people, who could rightfully see an arsenal of vulnerabilities in … Continue reading “Madrona, Trilogy Lead $1.2M Investment in Mobilisafe, Targeting Business IT Security Amid a Flood of Personal Gadgets”
Optimer Wins FDA Approval of New Antibiotic for Hospital Infections
Turns out that Optimer Pharmaceuticals won’t have to spend the holiday weekend on pins and needles. The San Diego-based biotech company got its wish today, as the FDA approved Optimer’s first new product for sale in the U.S. The FDA cleared fidaxomicin (Dificid) as a new treatment for C. difficile, a hardy bacterial infection that … Continue reading “Optimer Wins FDA Approval of New Antibiotic for Hospital Infections”
A Roundup of Summer Startup Competitions, from Healthcare IT to Dark Matter
You weren’t actually thinking about taking Memorial Day Weekend off, were you? If you’re an entrepreneur and you want some (relatively) easy money or fame, it’s time to get moving on your entry for one of the many startup-oriented competitions underway this summer. Here are just four that have hit my inbox this week. —Morgenthaler … Continue reading “A Roundup of Summer Startup Competitions, from Healthcare IT to Dark Matter”
Solazyme Finds Investor Appetite for Renewables, Sees Shares Boom on Day One
Solazyme must be getting ready for a heck of a company party this Memorial Day weekend. The renewable oils company pulled off its long-awaited IPO last night, and got a quite bullish (although not exactly LinkedIn-style) reaction from investors. South San Francisco-based Solazyme (NASDAQ: [[ticker:SZYM]]) raised more than $197 million through its initial public offering … Continue reading “Solazyme Finds Investor Appetite for Renewables, Sees Shares Boom on Day One”
UW Business Plan Competition Winners: Clean Water, Better Food, & Next-Gen Medical Scans
[Updated at 12:30 to correct grand prize amount] After nearly two months of development, pitching, advice, and several rounds of judging, the 2011 University of Washington Business Plan Competition is a wrap. The annual event drew 104 teams this year, which the UW’s Foster Business School says is a record. Last night, winners were named … Continue reading “UW Business Plan Competition Winners: Clean Water, Better Food, & Next-Gen Medical Scans”
Entrepreneurial Street Survival: The Essential AC/DC Songlist
This may give away my age and musical tastes, but I’ve noticed how entrepreneurs nearly always end up sounding like AC/DC. It’s hard. It takes a long time. Capital raising is brutal. It’s a Long Way to the Top if You Wanna Rock and Roll. Over the years, I’ve mentioned some of the following. It … Continue reading “Entrepreneurial Street Survival: The Essential AC/DC Songlist”
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News
This week was full with news of progress from New England drug developers. —Waltham, MA-based antibody drug maker ImmunoGen (NASDAQ: [[ticker:IMGN]]) sold 7 million shares of stock at $12 apiece. The company had $115.8 million in cash on hand at the end of March, a quarterly report showed. —Biogen Idec (NASDAQ: [[ticker:BIIB]]) of Weston, MA, … Continue reading “Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News”
Forget The iPhone. Your Car Is The Ultimate Mobile Device—But How Far Should That Go?
When a car today can parallel park on its own, find the best Mexican restaurant in a 10-block radius, and access e-mail on voice command, I suppose checking your blood sugar would just seem like icing on the cake. (Pun intended) “We are trying to create a car that cares,” says Gary Strumolo, manager of … Continue reading “Forget The iPhone. Your Car Is The Ultimate Mobile Device—But How Far Should That Go?”
Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic
At least a few people in San Diego are sitting tight today at work, unable to get a jump on the holiday weekend. That’s the case at San Diego-based Optimer Pharmaceuticals (NASDAQ: [[ticker:OPTR]]), which is awaiting word from the FDA on whether its first drug can be cleared for sale in the U.S. The agency’s … Continue reading “Optimer Cruises Into Memorable Memorial Day Weekend, Awaiting FDA Word on Antibiotic”
Fueled by Mobile Transaction Technology, Mitek Systems Raises $15M for Nasdaq Move
In the years after the Berlin Wall crumbled, San Diego’s Mitek Systems was one of many local defense contractors left high and dry by a receding tide of Pentagon spending. These days, however, the company is riding a wave of success with new technology that enables a person to use a smartphone camera to deposit … Continue reading “Fueled by Mobile Transaction Technology, Mitek Systems Raises $15M for Nasdaq Move”
Yes, Technology Is Taking Jobs Away, But Here’s How It Might Give Them Back
Back in March, I wrote a column arguing that smartphones, tablet computers, Internet TVs and other personal technologies are delivering an unexpected bonus. Rather than depreciating, the way most equipment does, these gadgets actually get more valuable over time thanks to the hundreds of new apps that debut every week, plus free upgrades for existing … Continue reading “Yes, Technology Is Taking Jobs Away, But Here’s How It Might Give Them Back”
SnapGoods Targets Consumers Who Want to Rent Instead of Buy
Brooklyn-based SnapGoods is looking to create a consumer space that does not involve buying or selling goods, but targets a third, often-neglected consumer: the one who simply wants to borrow stuff. “You use it, and then you give it back,” said Ron Williams, 34-year-old CEO and co-founder of the Brooklyn-based startup, a company whose tagline … Continue reading “SnapGoods Targets Consumers Who Want to Rent Instead of Buy”
Google’s Purchase of Sparkbuy: Sounds Like it’s More Than Just a Talent Acquisition
So, maybe Google’s purchase of startup electronics shopping site Sparkbuy wasn’t just a talent acquisition? That’s the word from Scott Silver, director of Google’s Kirkland, WA office, in a follow-up interview with The Seattle Times’ Brier Dudley. Dudley also reports that Google is eyeing the cluster of retail talent in the Seattle area, which has … Continue reading “Google’s Purchase of Sparkbuy: Sounds Like it’s More Than Just a Talent Acquisition”
Aneesh Chopra, Steve Jurvetson, Paul Saffo Debate Top Tech Trends, from Rosie the Robot to Augmented Reality
The Churchill Club, a networking group for Silicon Valley technology executives, hit the quarter-century mark in November, and for the last 13 of those 25 years, it’s organized an annual “Top 10 Tech Trends” dinner. The format is simple. A panelist or guest proposes a trend that will shape markets and define entrepreneurial opportunities over … Continue reading “Aneesh Chopra, Steve Jurvetson, Paul Saffo Debate Top Tech Trends, from Rosie the Robot to Augmented Reality”
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence
When Cambridge, MA-based Alnylam (NASDAQ: [[ticker:ALNY]]) made its debut last year at the annual American Society of Clinical Oncology (ASCO) conference, it only had a pittance of safety data on its drug, which is designed to treat advanced solid tumors that have spread to the liver. At this year’s conference, which starts June 3 in Chicago, … Continue reading “Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence”
Ann Arbor Spark Pats Its Back
Ann Arbor SPARK says it has attracted 13 new companies to the region and helped 29 businesses to expand in the region last year. The business accelerator also said it helped secure $151 million in new investment commitments and create over 1,400 new jobs.
Stage 2 Innovations CEO Offers Details On New $100 Million Fund
Simon Boag sounds downright sheepish. “We’re spoiled,” Boag, the new CEO of the $100 million Stage 2 Innovations Fund, told Xconomy. “We realize that. We’re extremely lucky to be in this position.” The fund, announced earlier this week, is targeting growth/expansion startups on the brink of commercializing their technology. An anonymous billionaire is putting up … Continue reading “Stage 2 Innovations CEO Offers Details On New $100 Million Fund”
Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With it
New York-based Pfizer (NYSE: [[ticker:PFE]]) is the biggest drug company in the world, so when it slashes costs and dumps drug candidates left and right, people take note. But sometimes what gets overlooked is that one company’s loss is another’s gain, and that’s what appears to be happening at South San Francisco-based Rigel Pharmaceuticals. Rigel … Continue reading “Rigel Pockets $130M in Financing, Seeks To Pick up Pfizer’s Ball and Run With it”
Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters
We are getting more and more excited about XSITE 2011—the Xconomy Summit on Innovation, Technology, and Entrepreneurship, our annual full-day innovation conference set to take place on June 16 at Babson College. We began announcing keynoters and other featured speakers several weeks ago, and the list has been building—to more than 40 speakers. They run … Continue reading “Agenda Announced for Most Exciting XSITE Yet: We Got 20-Plus Startups, Founders’ Stories, Incubator Debaters, & Provocative Keynoters”
Ford Lists Top 25 EV Cities, Highlights Pacific Coast Corridor for Future EV Road Trips
With the average price of gasoline reaching almost $4 a gallon nationwide, it’s safe to say a lot of people are curious about the all-electric vehicles (EV) that many automakers have been showing off lately. Still, it’s hard to justify the $100,000-plus sticker price for a Tesla Roadster or the $33,000 price of a Nissan … Continue reading “Ford Lists Top 25 EV Cities, Highlights Pacific Coast Corridor for Future EV Road Trips”
Accelerator’s New Cancer Startup, 23andMe Hanging at the ISB, How to Make $ With No IPO, & More in Seattle-Area Life Sciences News
This week’s biotech news roundup is short and sweet. —Accelerator, the Seattle-based hothouse for biotech startups, is humming with the activity of a new cancer drug startup called Oncofactor. This company is setting out to spur the immune system to fight tumors. —23andMe, the Mountain View, CA-based consumer genetic testing company, made an appearance at … Continue reading “Accelerator’s New Cancer Startup, 23andMe Hanging at the ISB, How to Make $ With No IPO, & More in Seattle-Area Life Sciences News”
Look Out, Mean Girls and Slackers: Objective Logistics Tracks Work Habits in Restaurants to Boost Sales
Slackers hate it. Go-getters love it. And store owners and managers? Well, so far they seem to be buying it. I’m talking about Objective Logistics, a New Bedford, MA-based software startup that’s looking to transform work environments, starting with restaurants and retail stores. “It’s polarizing as hell,” says CEO and co-founder Phil Beauregard. If you … Continue reading “Look Out, Mean Girls and Slackers: Objective Logistics Tracks Work Habits in Restaurants to Boost Sales”
With Esperion Reboot, Lipitor Co-Discoverer Roger Newton Pushes For Therapy Beyond Drugs
A few years ago, I went to see my doctor for a routine check-up. Blood tests showed I had a high count of low density lipoids (LDL), the so-called “bad cholesterol” that clogs arteries and causes heart attacks. “I’m prescribing you a statin,” the doctor said. I hesitated. “Uh….shouldn’t I try diet and exercise first?” … Continue reading “With Esperion Reboot, Lipitor Co-Discoverer Roger Newton Pushes For Therapy Beyond Drugs”
Emergence Capital: The Sequoia of SaaS, aka the House that Salesforce.com Built
Even in Silicon Valley, where the profusion of venture firms means that there’s a lot of specialization, you don’t often run into a firm as focused as Emergence Capital Partners. Many firms confine themselves to investing in Web or software startups, but Emergence is far narrower than that: the four-partner firm restricts itself solely to … Continue reading “Emergence Capital: The Sequoia of SaaS, aka the House that Salesforce.com Built”
Improving Health While Lowering Cost: Come Hear About the Grand Challenge of Healthtech at XSITE on June 16
Most days, I report and write about traditional things people would consider healthcare innovations with big business potential—new drugs, devices, and diagnostics. Most of these things end up adding costs to the healthcare system. But given the ever-rising costs of healthcare in the U.S., more and more entrepreneurial energy is being channeled in other ways … Continue reading “Improving Health While Lowering Cost: Come Hear About the Grand Challenge of Healthtech at XSITE on June 16”
Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs
Cambridge, MA-based Proteostasis Therapeutics has found a big new benefactor to support its R&D against neurological diseases. Proteostasis said today it has formed a strategic alliance with Ireland-based Elan to develop traditional small molecule drugs and diagnostics with Proteostasis against neurodegenerative diseases like Parkinson’s, Huntington’s, and multiple sclerosis. Elan, the developer of the hit multiple … Continue reading “Proteostasis Nabs Partnership, $20M Investment, from Elan To Pursue Neurology Drugs”
NYC Scientists Score $250,000 Awards in Annual BioAccelerate Competition
Five New York-based scientists—developing technologies ranging from replacement bones to prosthetic eyes—were named today as the winners of the 2011 BioAccelerate competition. Each will receive $250,000 from the New York City Investment Fund, which they will use to transform their technologies into commercial companies. BioAccelerate was launched two years ago to fill a gaping funding … Continue reading “NYC Scientists Score $250,000 Awards in Annual BioAccelerate Competition”
San Diego’s Trius Therapeutics Creates Options for the Next Generation of Antibiotics
San Diego’s Trius Therapeutics, like Zogenix and Pacira Pharmaceuticals, was among the local IPOs that got caught in the jaws of the amazing life sciences valuation-shrinking machine of 2010. Trius initially filed its IPO in late 2009 to raise as much as $86 million by March 2010, so the company could price its shares in … Continue reading “San Diego’s Trius Therapeutics Creates Options for the Next Generation of Antibiotics”
Seattle Goes Hollywood: Four Startups Aiming to Help Studios, Celebs Embrace the Digital Age
When Dave Long first started pitching movie studios on a new way to market their old titles, he encountered a fair bit of skepticism. After all, what could a boardgame entrepreneur from soggy Seattle possibly teach Hollywood about selling its own stars? Nearly 10 years later, the “Scene It?” brand—which builds trivia games around movie … Continue reading “Seattle Goes Hollywood: Four Startups Aiming to Help Studios, Celebs Embrace the Digital Age”
TenMarks, Education Software Startup, Looks to Improve Kids’ Math Skills as Summer Beckons
You wouldn’t know it from the weather until yesterday, but summer is on its way. Soon classes will be out of session and students of all ages will be running wild. What that means, besides more Commencement speeches (and, soon, being able to get a seat at a Harvard or Davis Square café), is that … Continue reading “TenMarks, Education Software Startup, Looks to Improve Kids’ Math Skills as Summer Beckons”
ImmunoGen Raises $84M, Cablevision Founder Backs Crimson Hexagon, BzzAgent Bought, & More Boston-Area Deals News
New England IT and life sciences startups warmed up this week with financing and acquisition news. —Andover, MA-based SiGe Semiconductor scrapped its plans to go public and was instead acquired by Skyworks Solutions (NASDAQ: [[ticker:SWKS]]) of Woburn, MA, for $210 million upfront and potentially $65 million more tied to certain milestones. —Nashua, NH-based VGo Communications, … Continue reading “ImmunoGen Raises $84M, Cablevision Founder Backs Crimson Hexagon, BzzAgent Bought, & More Boston-Area Deals News”
Show Me The Money! Ex-Chrysler CEO Co-founds New $100 Million Fund For Growth/Expansion Startups
Wow. Now that’s what I’m talking about. Automation Alley, a business accelerator based in Troy, MI that helps nurture local startups, today announced the creation of a $100 million fund to back local companies looking to take their fledgling businesses to a higher level. Chrysler CEO Tom LaSorda co-founded the fund, called Stage 2 Innovations … Continue reading “Show Me The Money! Ex-Chrysler CEO Co-founds New $100 Million Fund For Growth/Expansion Startups”
QD Vision, Crimson Hexagon, and Other Boston Startup Financings Fit Trend Across Industries
Busy day for company financings, as everyone gets ready for the holiday weekend (and unofficial start of summer). It’s worth noting the step up in dollar amounts as you go from Internet software and social media ($5M), to nanotech/materials ($22M), to cleantech and energy ($57M), to biotech/pharma and life sciences ($91M). Yes, biotech and energy … Continue reading “QD Vision, Crimson Hexagon, and Other Boston Startup Financings Fit Trend Across Industries”
Vizibility Lets You Dictate How Google Presents You to the World
Ever since the invention of search engines, entrepreneur James Alexander has been frustrated. “I could never find myself on the Internet,” says Alexander, who gets lost on the Web because of his common name, or as he puts it, his “two first names.” So in 2009, he started playing around with the “advanced search” option … Continue reading “Vizibility Lets You Dictate How Google Presents You to the World”
En Route to IPO, San Diego’s Prometheus Labs Detours to Nestlé Buyout
[Updated 5/24/11 9:25 am. See below.] San Diego’s Prometheus Laboratories, a specialty pharma and diagnostics company in registration for an IPO, has instead agreed to a buyout offer from Nestlé Health Science, a new subsidiary of Switzerland’s Nestlé S.A. [Updated with estimated buyout range.] Financial terms of the deal were not disclosed in a statement … Continue reading “En Route to IPO, San Diego’s Prometheus Labs Detours to Nestlé Buyout”
Desh Deshpande’s XSITE Keynote: Making an Impact Through Entrepreneurship Driven by Technological and Social Innovation
It is less than a month until XSITE 2011—the Xconomy Summit on Innovation, Technology, and Entrepreneurship, our annual full-day innovation extravaganza that will take place this year on June 16 at Babson College. We have already announced most of the keynoters and many other speakers, which you can find here, along with the registration information. … Continue reading “Desh Deshpande’s XSITE Keynote: Making an Impact Through Entrepreneurship Driven by Technological and Social Innovation”
GM Ventures Growing Up—A Quick Look at How it Operates and How Deals Work
General Motors launched its first venture capital fund—GM Ventures—last summer. We covered the news, and in December, still early in the $100 million fund’s life, I did a Q&A with GM Ventures president Jon Lauckner. At the time, the fund had invested in just two startups—battery maker Sakti3 and Bright Automotive, which offers a new … Continue reading “GM Ventures Growing Up—A Quick Look at How it Operates and How Deals Work”
Adam Wiggins on Heroku’s Pivot, Building a “Washing Machine” for Web Developers, and Joining Salesforce.com
If you had to name a single company whose storyline weaves through most of the big trends defining Internet startup life in Silicon Valley over the last few years—cloud computing, agile software development, the rise of venture incubators, and the software-as-a-service and platform-as-a-service phenomena—you couldn’t find a much better example than Heroku. From its humble … Continue reading “Adam Wiggins on Heroku’s Pivot, Building a “Washing Machine” for Web Developers, and Joining Salesforce.com”
Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing
Today marks a major milestone in Cambridge, MA-based Radius Health’s long quest to enter the multibillion-dollar osteoporosis market. The company announced that it has raised $91 million in a third financing round, which includes $66 million in equity. What’s more, upon the closing of the financing, Radius merged with an unlisted shell company (“MAC”), so … Continue reading “Radius Raises $91 Million to Advance Osteoporosis Drug, Makes Strides Towards Public Listing”
23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma
23andMe is used to lots of eye-rolling from scientists. One geneticist, quoted a year ago in the New York Times, ridiculed the Mountain View, CA-based maker of consumer genetic tests for providing little more than “a really wonderful form of recreation.” One year later, 23andMe CEO Anne Wojcicki stood in front of a room of … Continue reading “23andMe Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma”
Debit Cards Aren’t For Stupid People: Q&A with PerkStreet CEO on Flying Into the Startup Abyss
Dan O’Malley created a Web-based financial services company in 2008. Crazy, to put it in his words, since the financial markets were in meltdown mode. Now his startup, PerkStreet Financial, says it has more customers than half the banks and credit unions in the country each do. Boston-based PerkStreet has gotten plenty of buzz for … Continue reading “Debit Cards Aren’t For Stupid People: Q&A with PerkStreet CEO on Flying Into the Startup Abyss”
Building a Company That Stands for Something: A Video Interview With David Hauser
I had the pleasure of sitting down with David Hauser recently to talk about his Boston-area company, the Grasshopper Group. David is the CTO of the company and co-founded it with Siamak Taghaddos in 2003 when they were both students at Babson College. From its beginnings as a virtual phone system, the Grasshopper Group is now … Continue reading “Building a Company That Stands for Something: A Video Interview With David Hauser”
Microsoft Takes on Everybody, Google Buys Sparkbuy, More Fuel for the Talent Wars, & More in the Seattle-Area Tech Roundup
After maturing into a steady software company with a mammoth organizational chart, Microsoft is the source of plenty of eye-rolling in the world of tech upstarts—hometown fans included. But every so often, you see a glimpse of what the Redmond, WA-based tech titan could do if its energy was directed just right. We’ve certainly seen … Continue reading “Microsoft Takes on Everybody, Google Buys Sparkbuy, More Fuel for the Talent Wars, & More in the Seattle-Area Tech Roundup”
Michael Schreck Back in Boston as New Zmags CEO; Digital Publishing Firm Shifts to Commerce
Here in Boston, we fret about losing tech talent and leadership to the West Coast. So today, let’s celebrate the return of one of our own. Michael Schreck has joined Boston-based digital publishing firm Zmags as its new CEO, as of earlier this month. Schreck, a prominent investor and entrepreneur, has spent the past eight … Continue reading “Michael Schreck Back in Boston as New Zmags CEO; Digital Publishing Firm Shifts to Commerce”
Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer
Seattleites know better than most that the notion that you can spur the immune system to fight cancer is going through a renaissance. So it shouldn’t be any surprise that Accelerator’s newest startup, Oncofactor, is testing out a variation on this red-hot theme. Accelerator, the Seattle-based haven for biotech startups, has plunked down the first … Continue reading “Accelerator’s New Startup, Oncofactor, Seeks to Spark Immune System Fight Against Cancer”
IPO Pipeline Pumps Up the Volume in First Quarter
A recent study of IPO filings by the Ernst & Young accounting firm shows that 47 companies filed for initial public offerings during the quarter that ended March 31, and a total of 125 companies are waiting to go public on U.S. markets. Of the 125 companies in the pipeline, 25 are based in California, … Continue reading “IPO Pipeline Pumps Up the Volume in First Quarter”
Tech Talent Shortage, One of this Year’s Major Storylines, Illustrated in National Study by Job-Search Site Dice
If you want another bit of evidence that the technology job market is really competitive, job-search site Dice is out with a new study that ranks states according to their estimated shortage of new tech workers. Xconomy locations, which align with the top innovation clusters nationally, are well represented atop the list for having the … Continue reading “Tech Talent Shortage, One of this Year’s Major Storylines, Illustrated in National Study by Job-Search Site Dice”
Google Buys Sparkbuy, Less Than Two Months After Seattle Startup’s Product Launch
Sparkbuy, a consumer electronics shopping site based in Seattle, has been purchased by Google (NASDAQ: [[ticker:GOOG]]), the startup announced today on its website. The company, which has been around for less than a year, had raised about $1 million, led by Benaroya Ventures and angel investor Geoff Entress. Terms of the acquisition weren’t disclosed, but … Continue reading “Google Buys Sparkbuy, Less Than Two Months After Seattle Startup’s Product Launch”
LinkedIn, Eventbrite, Optimizely, Garageband: The 1-Minute Version of Last Week’s Bay Area BizTech News
Last week’s Xconomy event Beyond Mobile: Computing in 2021 (nicely summarized by freelancer David Needle) kept me pretty busy, but the news rolled on: —The biggest buzz of the week, of course, was over the initial public offering by Mountain View, CA-based LinkedIn (NYSE: [[ticker:LNKD]]), which brought the company some $352 million in new funds. … Continue reading “LinkedIn, Eventbrite, Optimizely, Garageband: The 1-Minute Version of Last Week’s Bay Area BizTech News”